FI803025A7 - Menetelmä farmakologisesti aktiivisten ergoliinijohdannaisten valmistamiseksi. - Google Patents

Menetelmä farmakologisesti aktiivisten ergoliinijohdannaisten valmistamiseksi. Download PDF

Info

Publication number
FI803025A7
FI803025A7 FI803025A FI803025A FI803025A7 FI 803025 A7 FI803025 A7 FI 803025A7 FI 803025 A FI803025 A FI 803025A FI 803025 A FI803025 A FI 803025A FI 803025 A7 FI803025 A7 FI 803025A7
Authority
FI
Finland
Prior art keywords
preparation
pharmacologically active
ergoline derivatives
active ergoline
derivatives
Prior art date
Application number
FI803025A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Edmund Carl Kornfeld
Nicholas James Bach
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI803025A7 publication Critical patent/FI803025A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI803025A 1979-10-01 1980-09-25 Menetelmä farmakologisesti aktiivisten ergoliinijohdannaisten valmistamiseksi. FI803025A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/080,768 US4246265A (en) 1979-10-01 1979-10-01 6-n-Propyl-8α-methoxymethyl or methylmercaptomethylergolines and related compounds

Publications (1)

Publication Number Publication Date
FI803025A7 true FI803025A7 (fi) 1981-01-01

Family

ID=22159504

Family Applications (1)

Application Number Title Priority Date Filing Date
FI803025A FI803025A7 (fi) 1979-10-01 1980-09-25 Menetelmä farmakologisesti aktiivisten ergoliinijohdannaisten valmistamiseksi.

Country Status (32)

Country Link
US (1) US4246265A (cg-RX-API-DMAC10.html)
EP (1) EP0026671B1 (cg-RX-API-DMAC10.html)
JP (1) JPS5657787A (cg-RX-API-DMAC10.html)
KR (1) KR830003478A (cg-RX-API-DMAC10.html)
AT (1) AT373251B (cg-RX-API-DMAC10.html)
AU (1) AU529508B2 (cg-RX-API-DMAC10.html)
BE (1) BE885385A (cg-RX-API-DMAC10.html)
BG (1) BG34908A3 (cg-RX-API-DMAC10.html)
CA (1) CA1137079A (cg-RX-API-DMAC10.html)
CH (1) CH645642A5 (cg-RX-API-DMAC10.html)
CS (1) CS223834B2 (cg-RX-API-DMAC10.html)
DD (1) DD153372A5 (cg-RX-API-DMAC10.html)
DE (1) DE3069771D1 (cg-RX-API-DMAC10.html)
DK (1) DK413780A (cg-RX-API-DMAC10.html)
EG (1) EG14583A (cg-RX-API-DMAC10.html)
ES (1) ES8200697A1 (cg-RX-API-DMAC10.html)
FI (1) FI803025A7 (cg-RX-API-DMAC10.html)
FR (1) FR2466465A1 (cg-RX-API-DMAC10.html)
GB (1) GB2058790B (cg-RX-API-DMAC10.html)
GR (1) GR70067B (cg-RX-API-DMAC10.html)
HU (1) HU181766B (cg-RX-API-DMAC10.html)
IE (1) IE50429B1 (cg-RX-API-DMAC10.html)
IL (1) IL61143A0 (cg-RX-API-DMAC10.html)
IT (1) IT1133631B (cg-RX-API-DMAC10.html)
NZ (1) NZ195053A (cg-RX-API-DMAC10.html)
PH (1) PH15021A (cg-RX-API-DMAC10.html)
PL (1) PL226917A1 (cg-RX-API-DMAC10.html)
PT (1) PT71840B (cg-RX-API-DMAC10.html)
RO (1) RO81115B (cg-RX-API-DMAC10.html)
SU (1) SU976851A3 (cg-RX-API-DMAC10.html)
YU (1) YU247280A (cg-RX-API-DMAC10.html)
ZA (1) ZA805959B (cg-RX-API-DMAC10.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH644606A5 (de) * 1980-09-23 1984-08-15 Sandoz Ag Verfahren zur isomerisierung von 9,10-dihydrolysergsaeurederivaten.
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
US4683313A (en) * 1985-06-24 1987-07-28 Eli Lilly And Company 2-alkyl(or phenyl)thio-6-N alkyl ergolines and 4-dialkylaminotetrahydrobenz[c,d]indoles
US4782152A (en) * 1985-08-16 1988-11-01 Eli Lilly And Company Decyanation of pergolide intermediate
US4772709A (en) * 1985-10-01 1988-09-20 Eli Lilly And Company Process of making ketoalkanol esters of dihydrolysergic acid
FR2589734B1 (fr) * 1985-11-13 1988-09-02 Roussel Uclaf Utilisation de derives de l'ergoline a l'obtention d'un medicament a visee geriatrique
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
DE3913756A1 (de) * 1989-04-21 1990-10-25 Schering Ag 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung
IT1307934B1 (it) 1999-01-27 2001-11-29 Poli Ind Chimica Spa Processo per la preparazione di derivati alchimercaptometilergolinici.
US6388079B1 (en) * 2000-08-29 2002-05-14 Scinopharm Singapore Pte Ltd. Process for preparing pergolide
US7019140B2 (en) 2002-03-15 2006-03-28 Antibioticos S.P.A. Process for the synthesis of pergolide
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
GB0409785D0 (en) * 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
US7339060B2 (en) 2005-03-23 2008-03-04 Resolution Chemicals, Ltd. Preparation of cabergoline
GB0505965D0 (en) * 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
US20070197576A1 (en) * 2006-02-08 2007-08-23 Resolution Chemicals Limited Production of Cabergoline and Novel Polymorphic Form Thereof
MX388192B (es) 2014-09-25 2025-03-19 Boehringer Ingelheim Vetmedica Gmbh Tratamiento de combinación y/o prevención de trastornos metabólicos en animales equinos.
WO2019234069A1 (en) 2018-06-08 2019-12-12 Boehringer Ingelheim Vetmedica Gmbh Liquid pharmaceutical compositions comprising pergolide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
DE2657771A1 (de) * 1976-01-02 1977-07-14 Sandoz Ag Neue organische verbindungen, ihre verwendung und herstellung
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4202979A (en) * 1979-01-11 1980-05-13 Eli Lilly And Company 6-Ethyl(or allyl)-8-methoxymethyl or methylmercaptomethylergolines and related compounds

Also Published As

Publication number Publication date
AT373251B (de) 1984-01-10
NZ195053A (en) 1983-07-29
YU247280A (en) 1983-02-28
CH645642A5 (fr) 1984-10-15
GB2058790A (en) 1981-04-15
SU976851A3 (ru) 1982-11-23
DE3069771D1 (en) 1985-01-17
IE802036L (en) 1981-04-01
JPS5657787A (en) 1981-05-20
US4246265A (en) 1981-01-20
BE885385A (fr) 1981-03-25
DD153372A5 (de) 1982-01-06
KR830003478A (ko) 1983-06-20
AU529508B2 (en) 1983-06-09
IE50429B1 (en) 1986-04-16
IT8025004A0 (it) 1980-09-29
AU6280780A (en) 1981-04-09
ES495520A0 (es) 1981-11-16
HU181766B (en) 1983-11-28
FR2466465A1 (fr) 1981-04-10
ZA805959B (en) 1982-04-28
EG14583A (en) 1985-03-31
EP0026671A1 (en) 1981-04-08
IT1133631B (it) 1986-07-09
RO81115B (ro) 1983-02-28
EP0026671B1 (en) 1984-12-05
ATA487480A (de) 1983-05-15
FR2466465B1 (cg-RX-API-DMAC10.html) 1983-11-25
RO81115A (ro) 1983-02-15
BG34908A3 (bg) 1983-12-15
GR70067B (cg-RX-API-DMAC10.html) 1982-07-26
PL226917A1 (cg-RX-API-DMAC10.html) 1981-06-05
PT71840A (en) 1980-10-01
ES8200697A1 (es) 1981-11-16
DK413780A (da) 1981-04-02
IL61143A0 (en) 1980-11-30
GB2058790B (en) 1983-06-08
CA1137079A (en) 1982-12-07
PT71840B (en) 1981-06-09
PH15021A (en) 1982-05-13
CS223834B2 (en) 1983-11-25

Similar Documents

Publication Publication Date Title
ES518692A0 (es) Metodo de preparacion de derivados farmaceuticamente activosaminoalcoil heterociclicos.
NO810765L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
FI803508A7 (fi) Menetelmä imidatsoli-5- etikkahappojohdannaisten valmistamiseksi.
NO800626L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive polyolderivater
NO153177C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater.
NO159016C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
NO159019C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 6beta-hydroksyalkylpenicillansyrederivater.
FI800143A7 (fi) Menetelmä imidatsolijohdannaisten valmistamiseksi.
FI803025A7 (fi) Menetelmä farmakologisesti aktiivisten ergoliinijohdannaisten valmistamiseksi.
NO162073C (no) Analogifremgangsmaate for fremstilling av farmakologiske aktive heterocykliske forbindelser.
NO802015L (no) Fremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.
FI831998A7 (fi) Menetelmä farmaseuttisesti aktiivisten pyratsinonijohdannaisten valmistamiseksi.
NO802762L (no) Fremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater
NO157503C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive azepinderivater.
NO841657L (no) Fremgangsmaate for fremstilling av ergolinderivater.
FI823336A7 (fi) Menetelmä farmaseuttisesti aktiivisten bentsamidijohdannaisten valmistamiseksi.
NO161066C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive kinolinderivater.
ES508031A0 (es) Procedimiento para preparar derivados de dihidropiridina.
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
AR222691A1 (es) Procedimiento de preparacion de derivados hidroxi-de 2-isopropilamino-pirimidina
FI792206A7 (fi) Menetelmä uusien oksadiatsolopyrimidiini-johdannaisten valmistamiseksi.
NO822119L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benztriazol-derivater.
NO148920C (no) Fremgangsmaate for fremstilling av fenyl-glycylklorid-hydroklorid-derivater.
NO780743L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner
FI842976A7 (fi) Menetelmä farmaseuttisesti aktiivisten aminopyrimidinonijohdannaisten valmistamiseksi.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: ELI LILLY AND COMPANY